Inferring drug-disease associations by a deep analysis on drug and disease networks
Drugs, which treat various diseases, are essential for human health. However, developing new drugs is quite laborious, time-consuming, and expensive. Although investments into drug development have greatly increased over the years, the number of drug approvals each year remain quite low. Drug repositioning is deemed an effective means to accelerate the procedures of drug development because it can discover novel effects of existing drugs. Numerous computational methods have been proposed in drug repositioning, some of which were designed as binary classifiers that can predict drug-disease associations (DDAs). The negative sample selection was a common defect of this method. In this study, a novel reliable negative sample selection scheme, named RNSS, is presented, which can screen out reliable pairs of drugs and diseases with low probabilities of being actual DDAs. This scheme considered information from k-neighbors of one drug in a drug network, including their associations to diseases and the drug. Then, a scoring system was set up to evaluate pairs of drugs and diseases. To test the utility of the RNSS, three classic classification algorithms (random forest, bayes network and nearest neighbor algorithm) were employed to build classifiers using negative samples selected by the RNSS. The cross-validation results suggested that such classifiers provided a nearly perfect performance and were significantly superior to those using some traditional and previous negative sample selection schemes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Mathematical biosciences and engineering : MBE - 20(2023), 8 vom: 26. Juni, Seite 14136-14157 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Lei [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Binary classification |
|---|
| Anmerkungen: |
Date Completed 11.09.2023 Date Revised 20.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3934/mbe.2023632 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361767331 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361767331 | ||
| 003 | DE-627 | ||
| 005 | 20231226085832.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3934/mbe.2023632 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1205.xml |
| 035 | |a (DE-627)NLM361767331 | ||
| 035 | |a (NLM)37679129 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Lei |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inferring drug-disease associations by a deep analysis on drug and disease networks |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.09.2023 | ||
| 500 | |a Date Revised 20.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Drugs, which treat various diseases, are essential for human health. However, developing new drugs is quite laborious, time-consuming, and expensive. Although investments into drug development have greatly increased over the years, the number of drug approvals each year remain quite low. Drug repositioning is deemed an effective means to accelerate the procedures of drug development because it can discover novel effects of existing drugs. Numerous computational methods have been proposed in drug repositioning, some of which were designed as binary classifiers that can predict drug-disease associations (DDAs). The negative sample selection was a common defect of this method. In this study, a novel reliable negative sample selection scheme, named RNSS, is presented, which can screen out reliable pairs of drugs and diseases with low probabilities of being actual DDAs. This scheme considered information from k-neighbors of one drug in a drug network, including their associations to diseases and the drug. Then, a scoring system was set up to evaluate pairs of drugs and diseases. To test the utility of the RNSS, three classic classification algorithms (random forest, bayes network and nearest neighbor algorithm) were employed to build classifiers using negative samples selected by the RNSS. The cross-validation results suggested that such classifiers provided a nearly perfect performance and were significantly superior to those using some traditional and previous negative sample selection schemes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a binary classification | |
| 650 | 4 | |a drug repositioning | |
| 650 | 4 | |a drug-disease association | |
| 650 | 4 | |a negative sample selection | |
| 650 | 4 | |a network embedding | |
| 650 | 4 | |a random forest | |
| 700 | 1 | |a Chen, Kaiyu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhou, Bo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Mathematical biosciences and engineering : MBE |d 2004 |g 20(2023), 8 vom: 26. Juni, Seite 14136-14157 |w (DE-627)NLM171741196 |x 1551-0018 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:8 |g day:26 |g month:06 |g pages:14136-14157 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3934/mbe.2023632 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 8 |b 26 |c 06 |h 14136-14157 | ||